Behavior change is hard. AspyreRx™ helps your patients succeed.

Now you can prescribe a proven treatment to help your patients make positive behavior changes to improve their type 2 diabetes

Introducing AspyreRx

  • Cognitive behavioral therapy: A tailored and structured approach that helps your patients identify and transform thoughts and behaviors contributing to their diabetes.

  • Clinically-proven: A randomized controlled trial demonstrated statistically significant and clinically meaningful reductions in A1c, plus improvements in systolic blood pressure, weight, mood, and quality of life.

  • Conveniently delivered: The 90-day treatment is available on a smartphone, and designed to be integrated into your diabetes care plan.

Available by prescription only

Behavior change is possible

AspyreRx has demonstrated that with appropriate structure and support, people can make and sustain positive lifestyle changes to help manage their diabetes

See how it works

A safe and effective treatment

The AspyreRx pivotal study

A 6-month randomized controlled study enrolled 726 participants with type 2 diabetes with a BMI of ≥ 25 kg/m² and baseline A1c between 7% and 11%.

668 participants completed device onboarding to enter the treatment phase of study. The study was designed to evaluate safety and effectiveness for type 2 diabetes after two 90-day treatment periods.

Results showed AspyreRx helped study participants reduce A1c, systolic blood pressure, and weight, while improving mood and quality of life.

A1c reduction
in clinical trial participants

A1c reduction with
greater use* of AspyreRx

A1c reduction in participants with baseline A1c ≥ 8.5%†

Lowered weight
and blood pressure

Fewer medication increases and adverse events

Improved mood
and quality of life

Broad eligibility criteria and decentralized recruitment ensured a nationally representative, diverse population enrolled across 6 U.S. States​

Study participants were recruited from California, Texas, Florida, Georgia, Illinois,
and New York

Results shown are changes from baseline at 180 days in participants using the AspyreRx treatment

*Results from those who completed 10 lessons in 90 days, and continued using app for an average of 180 days
† Data on file: Better Therapeutics

AspyreRx demonstrated statistically significant fewer adverse events and serious adverse events vs. Control​

Fewer AspyreRx participants required antihyperglycemic medication increases at 180 days vs. Control​

Your toolkit just got better

Now you have a consistent and scalable way to help your patients build the confidence and self-efficacy needed to better manage their diabetes

How do I prescribe AspyreRx?

Our online pharmacy partner, PhilRx, makes it easy to prescribe

Need more information?
We’re here to help.

Indications for use:

AspyreRx is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes. The device targets behavior to aid in the management of type 2 diabetes in patients who are under the care of a healthcare provider. AspyreRx provides cognitive behavioral therapy as a treatment that should be used adjunctively with standard of care.

Notes regarding indications for use:

  • The device is not intended for use as a stand-alone therapy.

  • The device is not a substitute for a patient’s prescribed therapy or medication.

  • The benefit of treatment with the device was not evaluated beyond 180 days of treatment. The ability of the device to prevent potential relapse into prior behaviors after treatment discontinuation has not been studied.

  • The benefit of the device without the use of study-related compensation for glycemic monitoring has not been evaluated.

  • The device should not be used by people with unstable psychiatric disorders.

  • The device should not be used by people with severe psychiatric disorders and is not intended for use as a treatment for any psychiatric disorder or symptom.